Alkem Laboratories Ltd.

View in App
3550.20 -101.45 ▼-2.8%

22 September 2023, 04:01:00 PM
Volume: 3,154

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alkemlabs.com
Market Cap 42,382.80 Cr.
Enterprise Value(EV) 41,073.06 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 95.62 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 37.13 Trailing Twelve Months Ending 2023-06
Industry PE 37.50 Trailing Twelve Months Ending 2023-06
Book Value / Share 780.54 Trailing Twelve Months Ending 2023-06
Price to Book Value 4.55 Calculated using Price: 3,550.20
Dividend Yield 1.41 Period Ending 2023-03
No. of Shares Subscribed 11.96 Cr. 119,565,000 Shares
FaceValue 2
About Alkem Laboratories Ltd.
The company is one of India's foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies. Steered by its industry experience of over four decades, it offers high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.

Alkem Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alkem Laboratories Ltd. Performance

View details >>
1 Day
-2.78%
1 Week
-3.45%
1 Month
-5.75%
3 Month
+6.09%
6 Month
+10.45%
1 Year
+8.40%
2 Year
-8.70%
5 Year
+70.62%
10 Year

Alkem Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.03 22.48 22.18 13.69 15.02 19.82 23.91 20.99 11.39
Return on Capital Employed (%) 13.27 23.10 21.31 17.86 16.49 18.71 22.56 18.69 13.09
Return on Assets (%) 8.16 14.59 16.61 9.91 10.66 13.92 16.66 14.50 7.99

Alkem Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 2,585 2,999 3,692 4,468 4,864 5,439 6,161 7,377 8,638 9,045
Non Curr. Liab. 324 201 -306 -401 -359 -289 -541 -751 -893 -688
Curr. Liab. 1,403 2,006 1,538 1,690 2,383 2,218 3,245 3,604 4,805 3,707
Minority Int. 86 95 115 122 133 148 181 209 390
Equity & Liab. 4,311 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454
Non Curr. Assets 2,709 2,953 2,250 2,955 2,997 3,284 3,507 3,483 4,325 3,724
Curr. Assets 1,602 2,338 2,769 2,917 4,013 4,204 5,506 6,923 8,434 8,606
Misc. Exp. not W/O
Total Assets 4,311 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454

Alkem Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 3,743 4,925 5,688 6,392 7,357 8,344 8,865 10,634 11,599 11,991
Other Income 181 240 112 115 88 104 233 163 216 231
Total Income 3,924 5,165 5,800 6,507 7,445 8,449 9,098 10,797 11,815 12,221
Total Expenditure -3,322 -4,072 -4,689 -5,383 -6,242 -6,871 -6,923 -8,581 -9,990 -10,195
PBIDT 603 1,093 1,111 1,124 1,202 1,578 2,176 2,216 1,826 2,026
Interest -81 -71 -45 -55 -55 -65 -59 -52 -107 -111
Depreciation -71 -93 -101 -143 -193 -253 -275 -304 -310 -307
Taxation -59 -176 -60 -288 -181 -110 -224 -164 -298 -343
Exceptional Items -15 -103 -103
PAT 392 752 905 638 774 1,149 1,618 1,680 1,007 1,163
Minority Interest -11 -13 -7 -13 -22 -33 -35 -23 -20
Share Associate
Other Related Items
Consolidated Net Profit 392 742 892 631 761 1,127 1,585 1,646 984 1,143
Adjusted EPS 33 62 75 53 64 94 133 138 82 96

Alkem Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 290 325 726 471 266 780 585 1,265 1,111 1,683
Cash Fr. Inv. 350 -237 202 -286 -357 -316 -741 -999 -1,435 113
Cash Fr. Finan. -600 -52 -927 -138 85 -379 79 -272 380 -1,761
Net Change 41 37 1 47 -7 84 -77 -5 55 35
Cash & Cash Eqvt 101 140 127 167 167 249 176 174 232 274

Alkem Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 58.84 58.84 57.13 57.13 57.14 57.16 57.16 57.16 57.16
Public 41.16 41.16 42.87 42.87 42.86 42.84 42.84 42.84 42.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alkem Laboratories Ltd. Announcements

View details >>
Thu, 21 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted.
Fri, 15 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Management
We wish to inform you that based on the recommendation of Nomination and Remuneration Committee the Board of Directors of the Company at its meeting held today i.e. 15th September 2023 has appointed Dr. Vikas Gupta as the Chief Executive Officer (CEO) of the Company with effect from 22nd September 2023.Necessary particulars in relation to the said appointment is enclosed herewith.
Thu, 14 Sep 2023
In Terms Of Regulation 30 Of The SEBI Listing Regulations And The Policy For Determination Of Materiality Of Events Or Information Of The Company
We hereby inform you that the Income Tax Department ("IT Department") is conducting a survey at some of our offices and subsidiaries. The Company is fully cooperating with the officials of the IT Department and are responding to the queries raised by them. This has no impact on the operations of the Company.This is the only information that we are able to provide at this stage. Once the survey by the IT Department concludes the Company will update the Stock Exchanges in case of any material information/event.Kindly take the same on your records

Alkem Laboratories Ltd. Technical Scans

View details >>
Fri, 22 Sep 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low

Alkem Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,508.75 1,131.60 -1.3%
Divi's Laboratories Ltd. 98,393.27 3,708.40 -1.0%
Cipla Ltd. 95,796.29 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. 92,004.31 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. 71,703.97 5,003.05 -0.3%
Mankind Pharma Ltd. 70,167.07 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. 62,653.02 1,853.55 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.19 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 66.64 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 30.73 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.48 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 107.60 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 54.74 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.79 1,853.55 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.50 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 3.93 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.75 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.47 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 5.73 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.54 1,853.55 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,853.55 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,853.55 -1.1%

Alkem Laboratories Ltd. FAQ's

What is Alkem Laboratories share price?
Can I buy Alkem Laboratories shares now?
What is the Dividend Yield of Alkem Laboratories?
What is the Market Cap of Alkem Laboratories?
What are the key metrics to analyse Alkem Laboratories?
What is the 52 Week High and Low of Alkem Laboratories?
What is the trend of Alkem Laboratories share price?